OSU—James Immunotherapy Management Clinic to focus on managing immune side effects and cancer control

A clinic at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and Pelotonia Immuno-Oncology Institute aims to help manage the autoimmune side effects of immunotherapy-based cancer treatment and allow patients to live the fullest life possible both during cancer treatment and long-term as a survivor.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

DOWNLOAD THE PDF

Table of Contents

YOU MAY BE INTERESTED IN

In Brief

Siemens Healthineers, Ohio State Wexner Medical Center form 10-year, $105M partnership

Siemens Healthineers and The Ohio State Wexner Medical Center have expanded their existing strategic relationship to form a 10-year, $105 million value partnership to foster breakthroughs in clinical care, in addition to their longstanding research collaboration.

December 06, 2024

Vol.50 No.45

Clinical Roundup

Ohio State completes first gene therapy for hemophilia B

A team at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute completed its first gene therapy for a patient with hemophilia B, the first at an adult medical center in Ohio.

December 06, 2024

Vol.50 No.45

In Brief

Paul Nurse receives 2024 Block Memorial Lectureship

Sir Paul Nurse is the recipient of the 26th Herbert and Maxine Block Memorial Lectureship Award for Distinguished Achievement in Cancer. A geneticist and cell biologist who shared the 2001 Nobel Prize in Physiology or Medicine, Nurse is founding director and chief executive officer of the Francis Crick Institute in London.

October 04, 2024

Vol.50 No.37

In Brief

Christian Rolfo named director of Ohio State Division of Medical Oncology

Christian Rolfo was named director of the Division of Medical Oncology at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. He will start on Aug. 15.

June 21, 2024

Vol.50 No.25

Clinical Roundup

Lifileucel shrinks tumors in mNSCLC in phase II trial

Researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute said results of a phase II, multi-center clinical trial revealed that a new type of cell therapy is a promising potential treatment option for patients with stage 4 lung cancer who were previously treated but later developed resistance to other therapies.

May 10, 2024

Vol.50 No.19

In Brief

Nationwide Children’s Hospital and OSUCCC—James open proton therapy center opens

Nationwide Children’s Hospital and The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute opened a $100 million, 55,000 square foot proton therapy center. It is the first treatment facility in central Ohio offering this highly targeted form of radiation therapy for treatment of complex tumors that cannot be removed through surgery.

January 05, 2024

Vol.50 No.01

OSU—James Immunotherapy Management Clinic to focus on managing immune side effects and cancer control

YOU MAY BE INTERESTED IN

Siemens Healthineers, Ohio State Wexner Medical Center form 10-year, $105M partnership

Ohio State completes first gene therapy for hemophilia B

Paul Nurse receives 2024 Block Memorial Lectureship

Christian Rolfo named director of Ohio State Division of Medical Oncology

Lifileucel shrinks tumors in mNSCLC in phase II trial

Nationwide Children’s Hospital and OSUCCC—James open proton therapy center opens

Renew today!

Subscriber content

Never miss an issue!

Login